Tecomaria Capensis (family: Bignoniaceae) also known as Cape-honeysuckle. The present work aims at evaluating the anti inflammatory activity of Tecomaria Capensis by HRBC membrane stabilization. The prevention of hypotonicity induced HRBC membrane lysis was taken as a measure of the anti inflammatory activity. 
Introduction
Tecomaria capensis (family: Bignoniaceae) also known as Cape-honeysuckle is a fast growing, scrambling shrub which may grow up to 2-3m high and spread more than 2.5m. Tecomaria capensis is an evergreen plant in warm climate areas but loses its leaves in colder areas. It has pinnately compound leaves that have oval leaflets with blunt teeth. Flowering time for this shrub is very erratic and often it flowers all year round. Flowers are orange in color. Plant is used as a traditional medicine to relieve pain and sleeplessness. Dried powdered bark infusions are taken for sleeplessness (Roberts1990), reported to induce sleep (Hutchings, 1996 
Materials and Methods

Plant material
The leaves of Tecomaria capensis were collected from Guntur, Andhra Pradesh. It was authenticated by Dr. S. M. Khasim, Department of Botany and Microbiology, Acharya Nagarjuna University, Nagarjuna nagar, Guntur.
Preparation of extract
The leaf part of Tecomaria capensis was dried at room temperature and grounded into powder and passed through 60# sieve. The powder (500gm) was extracted successively in soxhlet by ethanol, ethyl acetate and water. The sediments were filtered and the filtrate was dried at 400 ᵒC in an oven to get dried product. The different fractions obtained were used for further study. The samples were prepared by suspending the residues in hot water and used for anti-inflammatory study.
Screening of anti-inflammatory activity
The anti-inflammatory activity of leaf extract of Tecomaria capensis (THUNB) was determined by HRBC membrane stabilization method. Blood was collected from healthy volunteers. The collected blood was mixed with equal volume of (2% dextrose, 0.8% sodium citrate, 0.05% citric acid & 0.42% sodium chloride in water). The blood was centrifuged at 3000 rpm and packed cells were washed with isosaline (0.85%, pH 7.2) & 10% v/v suspension was made with isosaline. The assay mixture contained the drug (concentration as mentioned in Table 1 ).1 ml phosphate buffer (0.15M, pH7.4), 2ml of hyposaline (0.36%) 0.5 ml of HRBC suspension. Diclofenac was used as the reference drug. Instead of hyposaline, 2ml of distilled water was used as control. All the assay mixtures were incubated at 37 0 c for 30 minutes and centrifuged. The hemoglobin content in the supernant solution was estimated using colorimeter at 560 nm. The percentage hemolysis was calculated by assuming the haemolysis produced in the presence of distilled water as 100%. The percentage of HRBC membrane stabilization or protection was calculated using the following formula (Gandhidasan, 1991) .
% Protection = 100 -Optical density of drug treated sample Optical density of control X 100
Results and Discussion
The lysosomal enzymes released during inflammation produce a variety of disorders. The extra cellular activity of these enzymes is said to be related to acute or chronic inflammation. The non steroidal drugs act either by inhibiting these lysosomal enzymes or by stabilizing the lysosomal membrane (Rajendran Vadivu, 2008 
Conclusion
From the above study it was concluded that the ethanolic extract of Tecomaria capensis has significant anti inflammatory activity (membrane stabilization property) in comparison to aqueous extract and ethyl acetate extract of the same plant and with standard drug diclofenac. The extracts exhibited membrane stabilization effect by inhibiting hypotonicity induced lysis of erythrocyte membrane. The erythrocyte membrane is analogus to the lysosomal membrane (Chou, 1997) and its stabilization implies that the extract may as well stabilize lysosomal membrane. Stabilization of lysosomal membrane is important in limiting the inflammatory response by preventing the release of lysosomal constituents of activated neutrophil such as bacterial enzymes and proteases which cause further tissue inflammation and damage (Murugasan, 1981) .
